DMI-Logo
search-iconsearch-icon

Oncology Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Oncology
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2026 August 22
Synthetic Lethality Drugs Market for PARP Inhibitors, ATR, WEE1, USP1, POLQ and Biomarker-Led Oncology 2026-2035
The synthetic lethality drugs market reached US$ 6.42 billion in 2025 and is projected to reach US$ 19.58 billion by 2035, growing at 11.8% CAGR as PARP inhibitors, ATR, WEE1, USP1, POLQ, PRMT5 and biomarker-selected oncology therapies advance.
Starting from
$4350$2999
Published: 2026 August 17
Next Generation Sequencing (NGS) Market Size, Share Analysis, Growth Trends and Forecast 2026-2033
Next Generation Sequencing (NGS) market size reached US$15.2 billion in 2024 and is expected to reach US$35.92 billion by 2033, growing at a CAGR of 11.6% during the forecast period 2026-2033.
Starting from
$4350$2999
Published: 2026 August 15
Desmoid Tumors Market- Size, Share and Forecast Analysis (2026-2033)
Explore the global Desmoid Tumors Market size, trends, and forecasts to 2033. Learn how Ogsiveo approval, targeted therapy, and R&D are driving growth.
Starting from
$4350$2999
Published: 2026 August 14
Global Cancer Monoclonal Antibodies Market Size, Share & Forecast (2026-2033)
The Cancer Monoclonal Antibodies Market is expected to reach at a CAGR of 11.4% during the forecast period 2026-2033 | DataM Intelligence
Starting from
$4350$2999
Published: 2026 August 10
Leukemia Therapeutics Market Size, Share, Precision Treatment Trends and Forecast 2035
Leukemia therapeutics market reached USD 18.87 billion in 2025 and is forecast to reach USD 35.76 billion by 2035 at a 6.6% CAGR.
Starting from
$4350$2999
Published: 2026 July 31
CAR-T Cell Therapy for Pediatric Cancers Market Size, Share, Growth Trends and Forecast 2026-2035
The global CAR-T Cell Therapy for Pediatric Cancers market was valued at US$ 2.24 billion in 2025 and is projected to reach US$ 24.03 billion by 2035, growing at a CAGR of 26.80% during the forecast period.
Starting from
$4350$2999
Published: 2026 July 26
Uveal Melanoma Treatment Market Size, Share, Industry, Forecast and Outlook (2026-2033)
The Global Uveal Melanoma Treatment Market is expected to reach at a CAGR of 7.5% during the forecast period 2026-2033 | DataM Intelligence
Starting from
$4350$2999
Published: 2026 July 21
Prostate Cancer Market Size, Growth, Industry Outlook (2026–2033)
The global prostate cancer market is projected to grow from US$14.25 billion in 2025 to US$28.10 billion by 2033, registering a CAGR of 7.8% during the forecast period 2026-2033.
Starting from
$4350$2999
Published: 2026 July 19
Japan CAR-T Cell Therapies Market Size, Share Analysis, Growth Insights and Forecast 2026-2033
The Japan CAR-T Cell Therapies Market reached US$ 402.40 million in 2025 and is expected to reach US$ 1,350.15 million by 2033, growing at a CAGR of 16.3% during the forecast period 2026-2033.
Starting from
$3175$2189
Published: 2026 July 16
Peptide Drug Conjugate Market Size, Pipeline, Trends and Forecast to 2035
Peptide Drug Conjugate market to reach US$ 25.90 billion by 2035 from US$ 4.53 billion in 2025, growing at 19.0% CAGR across oncology and genetic diseases.
Starting from
$4350$2999